Click Therapeutics Secures $20 Million Debt Financing from HSBC
Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has closed on a $20 million term loan from HSBC Innovation Banking, a division of HSBC Bank USA, N.A.
- Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that it has closed on a $20 million term loan from HSBC Innovation Banking, a division of HSBC Bank USA, N.A.
- The term loan was partially drawn at closing, with the proceeds used to retire Click’s previous term loan.
- “The last few years have been a period of tremendous growth for Click, and we could not be more excited to partner with HSBC Innovation Banking, a leader in the innovation economy,” said Randall Stanicky, Chief Financial Officer of Click Therapeutics.
- Click is also progressing its lead internal program for the preventive treatment of migraine with pivotal data expected in 2024.